Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Safinamide> ?p ?o }
- Safinamide abstract "Safinamide (INN; brand name Xadago, former developmental code name EMD-1195686) is a drug indicated for the treatment of Parkinson's disease with multiple methods of action. In 2007, a Phase III clinical trial was started. It was scheduled to run until 2011. The compound was originally discovered at Farmitalia-Carlo Erba and developed by Newron Pharmaceuticals, which sold the rights to Merck-Serono in 2006. In October 2011 Merck-Serono announced that they would give all rights to develop the compound back to Newron.Potential additional uses might be restless legs syndrome (RLS) and epilepsy. They were being tested in Phase II trials in 2008, but no results are available.".
- Safinamide atcPrefix "none".
- Safinamide casNumber "133865-89-1".
- Safinamide casSupplemental "(mesylate)".
- Safinamide fdaUniiCode "90ENL74SIG".
- Safinamide iupacName "N2-{4-[(3-fluorobenzyl)oxy]benzyl}-(L)-alaninamide".
- Safinamide pubchem "131682".
- Safinamide thumbnail Safinamide.svg?width=300.
- Safinamide wikiPageID "18911525".
- Safinamide wikiPageLength "7344".
- Safinamide wikiPageOutDegree "28".
- Safinamide wikiPageRevisionID "685352660".
- Safinamide wikiPageWikiLink Calcium_channel_blocker.
- Safinamide wikiPageWikiLink Category:Calcium_channel_blockers.
- Safinamide wikiPageWikiLink Category:Dopamine_reuptake_inhibitors.
- Safinamide wikiPageWikiLink Category:Monoamine_oxidase_inhibitors.
- Safinamide wikiPageWikiLink Category:Organofluorides.
- Safinamide wikiPageWikiLink Category:Sodium_channel_blockers.
- Safinamide wikiPageWikiLink Dopamine.
- Safinamide wikiPageWikiLink Dopamine_reuptake_inhibitor.
- Safinamide wikiPageWikiLink Epilepsy.
- Safinamide wikiPageWikiLink European_Medicines_Agency.
- Safinamide wikiPageWikiLink Evenamide.
- Safinamide wikiPageWikiLink Farmitalia-Carlo_Erba.
- Safinamide wikiPageWikiLink Glutamic_acid.
- Safinamide wikiPageWikiLink International_nonproprietary_name.
- Safinamide wikiPageWikiLink Lacosamide.
- Safinamide wikiPageWikiLink Merck_Serono.
- Safinamide wikiPageWikiLink Mesylate.
- Safinamide wikiPageWikiLink Monoamine_oxidase_inhibitor.
- Safinamide wikiPageWikiLink Newron_Pharmaceuticals.
- Safinamide wikiPageWikiLink Parkinsons_disease.
- Safinamide wikiPageWikiLink Pharmaceutical_drug.
- Safinamide wikiPageWikiLink Phases_of_clinical_research.
- Safinamide wikiPageWikiLink Placebo.
- Safinamide wikiPageWikiLink Ralfinamide.
- Safinamide wikiPageWikiLink Restless_legs_syndrome.
- Safinamide wikiPageWikiLink Sodium_channel_blocker.
- Safinamide wikiPageWikiLink Ziconotide.
- Safinamide wikiPageWikiLink nowiki%3E4-%5B(3-Fluorophenyl)methoxy%5Dphenyl%5D_methylamino%5Dpropanamide.
- Safinamide wikiPageWikiLinkText "Safinamide".
- Safinamide atcPrefix "none".
- Safinamide c "17".
- Safinamide casNumber "133865".
- Safinamide chembl "396778".
- Safinamide chemspiderid "116349".
- Safinamide f "1".
- Safinamide h "19".
- Safinamide inchi "1".
- Safinamide inchikey "NEMGRZFTLSKBAP-LBPRGKRZBO".
- Safinamide iupacName "N2-{4-[oxy]benzyl}-(L)-alaninamide".
- Safinamide kegg "D10158".
- Safinamide legalStatus "Investigational".
- Safinamide molecularWeight "302.34".
- Safinamide n "2".
- Safinamide o "2".
- Safinamide pubchem "131682".
- Safinamide smiles "O=C[C@@H]C".
- Safinamide stdinchi "1".
- Safinamide stdinchikey "NEMGRZFTLSKBAP-LBPRGKRZSA-N".
- Safinamide synonyms "-2".
- Safinamide unii "90".
- Safinamide verifiedfields "changed".
- Safinamide verifiedrevid "464386010".
- Safinamide wikiPageUsesTemplate Template:Antiparkinson.
- Safinamide wikiPageUsesTemplate Template:CAS.
- Safinamide wikiPageUsesTemplate Template:Cascite.
- Safinamide wikiPageUsesTemplate Template:Channelergics.
- Safinamide wikiPageUsesTemplate Template:Chemspidercite.
- Safinamide wikiPageUsesTemplate Template:Dopaminergics.
- Safinamide wikiPageUsesTemplate Template:Drugbankcite.
- Safinamide wikiPageUsesTemplate Template:Drugbox.
- Safinamide wikiPageUsesTemplate Template:Ebicite.
- Safinamide wikiPageUsesTemplate Template:Fdacite.
- Safinamide wikiPageUsesTemplate Template:Glutamatergics.
- Safinamide wikiPageUsesTemplate Template:Keggcite.
- Safinamide wikiPageUsesTemplate Template:Reflist.
- Safinamide wikiPageUsesTemplate Template:Stdinchicite.
- Safinamide subject Category:Calcium_channel_blockers.
- Safinamide subject Category:Dopamine_reuptake_inhibitors.
- Safinamide subject Category:Monoamine_oxidase_inhibitors.
- Safinamide subject Category:Organofluorides.
- Safinamide subject Category:Sodium_channel_blockers.
- Safinamide hypernym Drug.
- Safinamide type ChemicalSubstance.
- Safinamide type Drug.
- Safinamide type Antidepressant.
- Safinamide type Chemical.
- Safinamide type Drug.
- Safinamide type Inhibitor.
- Safinamide type Organofluoride.
- Safinamide type Organohalide.
- Safinamide type Organofluoride.
- Safinamide type Organohalide.
- Safinamide type ChemicalObject.
- Safinamide type Thing.
- Safinamide type Q8386.
- Safinamide comment "Safinamide (INN; brand name Xadago, former developmental code name EMD-1195686) is a drug indicated for the treatment of Parkinson's disease with multiple methods of action. In 2007, a Phase III clinical trial was started. It was scheduled to run until 2011. The compound was originally discovered at Farmitalia-Carlo Erba and developed by Newron Pharmaceuticals, which sold the rights to Merck-Serono in 2006.".
- Safinamide label "Safinamide".
- Safinamide sameAs Q2211523.